Opportunistic Valvular Screening: How Routine ECG-AI Expands the Structural Heart Pipeline
Dr. Dereck Mush, MD, MBAVendor Directory/Data Platforms
Tempus
Precision medicine company combining genomic and clinical data to inform treatment.
What they do
Tempus operates a technology platform that analyzes clinical and molecular data to support precision medicine decisions. The company provides genomic sequencing and data services to oncologists and researchers.
Who they serve
- Health systems
- Life sciences
Certifications
- CLIA
- CAP
Directory entries are compiled by The HealthTech Signal from public sources. Inclusion is editorial and not paid placement.
Related on The Signal
Dr. Dereck Mush, MD, MBA
The ECG-to-Echo Pathway: Where Tempus ECG-MR Must Prove Its Value
Dr. Dereck Mush, MD, MBA
The EHR Dark Data Goldmine: Why Sentence-Level Provenance Is Pharma's New Real-World Evidence Moat
Dr. Dereck Mush, MD, MBA
The Agentic Clinical AI Regulatory Frontier: What ADVOCATE's $62.7M Contract Actually Unlocks
Dr. Dereck Mush, MD, MBAKeep exploring